OBJECTIVE: To determine whether neurodevelopmental treatment (NDT) in the care of @entity64 @entity1 is effective with respect to the functional status and quality of life (QoL) during one year after @entity64 onset. DESIGN: Prospective, non-randomised, comparative parallel group design. METHODS: 324 consecutive @entity64 @entity1 from 12 Dutch hospitals were divided into 2 groups: an experimental group (n=223), in which nurses and physiotherapists used the NDT approach, and a control group who received conventional therapy (n=101). Functional status was assessed with the Barthel Index. Primary outcome was considered poor when the Barthel Index <12 after 1 year or when the @entity1 had died. QoL was assessed with the ' @entity64 adapted sickness impact profile'-30 and on a visual analogue scale. RESULTS: At 12 months, 59 @entity1 in the NDT group (26%) and 24 @entity1 in the control group (24%) had a poor outcome (corresponding adjusted odds ratio: 1.7; 95% CI: 0.8-3.5). At point of discharge and after 6 months, the adjusted odds ratio was 0.8 (95% CI: 0.4-1-5) and 1.6 (95% CI: 0.8-3.2) respectively. The adjusted mean differences of the QoL measurements did not show statistically significant differences between the 2 study groups at 6 and 12 months after @entity64 onset. CONCLUSION: The NDT approach was not an effective method in the care of @entity64 @entity1 . Health care professionals need to reconsider the use of the NDT approach.

['Neurodevelopmental treatment' following XXXX : no beneficial effect shown in measurements taken after 1 year; comparative study].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke', 'Stroke']
@entity64 :: (MESH:D020521,Disease) :: ['stroke']
